An Anti-PF4 Antibody-related Disorder with Cerebral Venous Sinus Thrombosis and Thrombocytopenia Initially Presenting As Intracranial Hemorrhage
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Greinacher A, Thiele T, Warkentin T, Weisser K, Kyrle P, Eichinger S
. Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination. N Engl J Med. 2021; 384(22):2092-2101.
PMC: 8095372.
DOI: 10.1056/NEJMoa2104840.
View
2.
Zlamal J, Singh A, Weich K, Jaffal H, Uzun G, Pelzl L
. Platelet phosphatidylserine is the critical mediator of thrombosis in heparin-induced thrombocytopenia. Haematologica. 2023; 108(10):2690-2702.
PMC: 10542843.
DOI: 10.3324/haematol.2022.282275.
View
3.
Schonborn L, Esteban O, Wesche J, Dobosz P, Broto M, Puig S
. Anti-PF4 immunothrombosis without proximate heparin or adenovirus vector vaccine exposure. Blood. 2023; 142(26):2305-2314.
PMC: 10862238.
DOI: 10.1182/blood.2023022136.
View
4.
Lindhoff-Last E, Schonborn L, Zaninetti C, Warkentin T, Greinacher A
. Rescue Therapy in Chronic Prothrombotic Autoimmune Anti-PF4 Disorder. N Engl J Med. 2023; 389(14):1339-1341.
DOI: 10.1056/NEJMc2309016.
View
5.
Brannagan 3rd T
. Intravenous gammaglobulin (IVIg) for treatment of CIDP and related immune-mediated neuropathies. Neurology. 2002; 59(12 Suppl 6):S33-40.
DOI: 10.1212/wnl.59.12_suppl_6.s33.
View